Medios AG (OTCMKTS:MEDOF) Shares Shorted: Short Interest Up 215.3% in October

Medios AG (OTCMKTS:MEDOF) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 2,705 shares, a growth of 215.3% from the September 30th total of 858 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Medios Stock Performance

MEDOF opened at C$13.64 on Thursday. The company’s 50 day moving average is C$13.64 and its 200-day moving average is C$13.64. Medios has a 1-year low of C$13.64 and a 1-year high of C$13.64.

Wall Street Analysts Forecast Growth

Separately, Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Medios in a report on Thursday, August 13th. One analyst has rated the stock with a Buy rating. According to data from MarketBeat.com, the company has a consensus rating of “Buy”.

About Medios

Medios AG is a Germany-based specialty pharmaceutical company headquartered in Berlin. The company focuses on supplying medicines and services for complex, often chronic or rare diseases, supporting healthcare providers and pharmacies involved in specialized patient care.

Its activities include the procurement, distribution and supply of specialty pharmaceuticals, as well as the preparation of patient-specific medications. Medios also provides pharmaceutical compounding services, producing individualized therapies in accordance with medical prescriptions and applicable quality standards.

Medios serves customers primarily in Germany through relationships with pharmacies, hospitals, medical practices and other healthcare partners.